Cargando…
Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
BACKGROUND: Dementia-related neuropsychiatric symptoms (NPS) are the main determinant of family stress and institutionalization of patients. This study aimed to identify inequalities by gender and socioeconomic status in the management of NPS in patients diagnosed with dementia. METHODS: An observat...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657654/ https://www.ncbi.nlm.nih.gov/pubmed/31413574 http://dx.doi.org/10.2147/NDT.S209008 |
_version_ | 1783438828628869120 |
---|---|
author | Mar, Javier Arrospide, Arantzazu Soto-Gordoa, Myriam Iruin, Álvaro Tainta, Mikel Gabilondo, Andrea Mar-Barrutia, Lore Calvo, Montserrat Mateos, Maider Ibarrondo, Oliver |
author_facet | Mar, Javier Arrospide, Arantzazu Soto-Gordoa, Myriam Iruin, Álvaro Tainta, Mikel Gabilondo, Andrea Mar-Barrutia, Lore Calvo, Montserrat Mateos, Maider Ibarrondo, Oliver |
author_sort | Mar, Javier |
collection | PubMed |
description | BACKGROUND: Dementia-related neuropsychiatric symptoms (NPS) are the main determinant of family stress and institutionalization of patients. This study aimed to identify inequalities by gender and socioeconomic status in the management of NPS in patients diagnosed with dementia. METHODS: An observational study was carried out to study all the cases of dementia in the corporate database of the Basque Health Service (29,864 patients). The prescription of antipsychotics and antidepressants and admission to a nursing home were used to establish the presence of NPS. The socioeconomic status of individuals was classified by a deprivation index. Logistic regressions were used to identify drivers for drug prescriptions and institutionalization. RESULTS: NPS are poorly recorded in the clinical databases (12%). Neuropsychiatric symptoms were severe enough in two thirds of patients with dementia to be treated with psychoactive medication. Institutionalization showed an increase from those who did not receive medication to those who had been prescribed antidepressants (OR: 1.546), antipsychotics (OR: 2.075) or both (OR: 2.741). The resulting inequalities were the increased prescription of antidepressant drugs in women and more nursing-home admissions for women who were the least socioeconomically deprived and men who were the most deprived. CONCLUSIONS: In large clinical databases, psychoactive drugs prescriptions can be useful to underscore the considerable burden of dementia-related NPS. Specific tools are needed to monitor social and health care programs targeted to dementia-related NPS from a population perspective. Programs aimed at reducing the family burden of care of dementia patients at home become the key elements in reducing inequalities in these patients’ care. Socioeconomic status is the most important driver of inequality, and gender inequality may simply be hidden within the social environment. Integrated programs boosting the continuity of care are an objective for which compliance could be measured according to the NPS coding in the electronic health record. |
format | Online Article Text |
id | pubmed-6657654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-66576542019-08-14 Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization Mar, Javier Arrospide, Arantzazu Soto-Gordoa, Myriam Iruin, Álvaro Tainta, Mikel Gabilondo, Andrea Mar-Barrutia, Lore Calvo, Montserrat Mateos, Maider Ibarrondo, Oliver Neuropsychiatr Dis Treat Original Research BACKGROUND: Dementia-related neuropsychiatric symptoms (NPS) are the main determinant of family stress and institutionalization of patients. This study aimed to identify inequalities by gender and socioeconomic status in the management of NPS in patients diagnosed with dementia. METHODS: An observational study was carried out to study all the cases of dementia in the corporate database of the Basque Health Service (29,864 patients). The prescription of antipsychotics and antidepressants and admission to a nursing home were used to establish the presence of NPS. The socioeconomic status of individuals was classified by a deprivation index. Logistic regressions were used to identify drivers for drug prescriptions and institutionalization. RESULTS: NPS are poorly recorded in the clinical databases (12%). Neuropsychiatric symptoms were severe enough in two thirds of patients with dementia to be treated with psychoactive medication. Institutionalization showed an increase from those who did not receive medication to those who had been prescribed antidepressants (OR: 1.546), antipsychotics (OR: 2.075) or both (OR: 2.741). The resulting inequalities were the increased prescription of antidepressant drugs in women and more nursing-home admissions for women who were the least socioeconomically deprived and men who were the most deprived. CONCLUSIONS: In large clinical databases, psychoactive drugs prescriptions can be useful to underscore the considerable burden of dementia-related NPS. Specific tools are needed to monitor social and health care programs targeted to dementia-related NPS from a population perspective. Programs aimed at reducing the family burden of care of dementia patients at home become the key elements in reducing inequalities in these patients’ care. Socioeconomic status is the most important driver of inequality, and gender inequality may simply be hidden within the social environment. Integrated programs boosting the continuity of care are an objective for which compliance could be measured according to the NPS coding in the electronic health record. Dove 2019-07-17 /pmc/articles/PMC6657654/ /pubmed/31413574 http://dx.doi.org/10.2147/NDT.S209008 Text en © 2019 Mar et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Mar, Javier Arrospide, Arantzazu Soto-Gordoa, Myriam Iruin, Álvaro Tainta, Mikel Gabilondo, Andrea Mar-Barrutia, Lore Calvo, Montserrat Mateos, Maider Ibarrondo, Oliver Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization |
title | Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization |
title_full | Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization |
title_fullStr | Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization |
title_full_unstemmed | Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization |
title_short | Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization |
title_sort | dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657654/ https://www.ncbi.nlm.nih.gov/pubmed/31413574 http://dx.doi.org/10.2147/NDT.S209008 |
work_keys_str_mv | AT marjavier dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization AT arrospidearantzazu dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization AT sotogordoamyriam dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization AT iruinalvaro dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization AT taintamikel dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization AT gabilondoandrea dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization AT marbarrutialore dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization AT calvomontserrat dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization AT mateosmaider dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization AT ibarrondooliver dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization |